24 May 2013
Keywords: update, novartis, glivec, oked, first-line, cml, swiss
Article | 06 January 2003
Swiss drug major Novartis has reported that its Gleevec/ Glivec(imatinib mesylate) has been approved in both the USA and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 January 2003
6 January 2003
3 February 2003
© 2013 thepharmaletter.com